Medifast reported a $17.5 million Q3 2026 loss driven by restructuring, while coach productivity rose 54% and management ...

A new study suggests that women using menopause hormone therapy alongside GLP-1 medications like Wegovy may experience greater weight loss.

Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy™, today reported results for the third quarter ended ...

Trisha Yearwood has been candid about dieting and weight loss over the years. Here’s everything to know about Trisha Yearwood ...

The Menopause Society noted that middle-aged women commonly experience weight gain resulting from menopause, and have turned to GLP-1 drugs for help. About 1 in 5 women 50 to 64 are or have used a GLP ...

Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster ...

Weight loss medications are not right for everyone, but more people qualify than you might think. Most adults can be ...

Osara Health has partnered with Medibank, one of Australia's largest private health insurers, to offer its evidence-based ...

A new experimental injection is drawing attention after researchers reported an average 12.01% reduction in visceral abdominal fat four weeks after treatment. Taiwan-based Caliway Biopharmaceuticals ...

Doctors say GLP-1 drugs can be an effective treatment, but research continues to explore what long-term use means for ...

Recent trials investigating the oral weight loss drug Orforglipron, also known as Foundayo, suggest that the medication shows ...

The food noise stopped. It's a common response from people taking GLP-1 receptor agonists, referring to the relentless internal monologue that once revolved around food cravings: A few chips won't ...